H. Lundbeck A/s

This study is testing whether a new drug called amlenetug can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder. About 357 people with MSA will receive either the drug or a placebo via monthly IV infusions for 72 weeks, with an option t…

This study is testing an investigational drug called Lu AG22515 to see if it can reduce eye bulging in people with moderate-to-severe Thyroid Eye Disease. It follows 20 adults for 24 weeks to measure changes in eye protrusion and track how the drug moves through the body. The goa…

This study is testing a new drug called Lu AG09222 to see if it can help prevent migraines in people who have already tried 1 to 4 other preventive medications without success. About 874 participants will receive either the new drug at different doses or a placebo (an inactive su…

This study is testing an investigational drug called Lu AF82422 to see if it can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder. About 64 participants with MSA will receive either the drug or a placebo for nearly a year to compare th…

This study is testing whether a migraine prevention drug called eptinezumab can help people who still have frequent migraines despite trying other similar preventive medications. It will involve about 150 adults who have at least 8 migraine days per month. The main goal is to see…

This study aims to better understand how Multiple System Atrophy (MSA) progresses over time. Researchers will follow 90 patients in China and Europe, tracking their symptoms and using MRI scans and blood tests to look for biological markers of the disease. The goal is to gather d…